Ganciclovir Antiviral Therapy in Advanced Idiopathic Pulmonary Fibrosis: An Open Pilot Study

Sureshbabu, A., Tonner, E., Allan, G. J., & Flint, D. J. (2011). Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis. Pulmonary Medicine, 2011(), 157-162. https://doi.org/10.1155/2011/517687
Tauler, J., & Mulshine, J. L. (2008). Combination Therapy of PPARγ Ligands and Inhibitors of Arachidonic Acid in Lung Cancer. PPAR Research, 2008(), 1023-1029-100. https://doi.org/10.1155/2008/750238
Bargagli, E., Prasse, A., Olivieri, C., Quernheim, J., & Rottoli, P. (2011). Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis. Pulmonary Medicine, 2011(), 224-230. https://doi.org/10.1155/2011/717130
Drakopanagiotakis, F., Xifteri, A., Tsiambas, E., Karameris, A., Tsakanika, K., Karagiannidis, N., Mermigkis, D., Polychronopoulos, V., & Bouros, D. (2012). Decreased Apoptotic Rate of Alveolar Macrophages of Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Medicine, 2012(), 764-772. https://doi.org/10.1155/2012/981730
Tzouvelekis, A., Bouros, E., Oikonomou, A., Ntolios, P., Zacharis, G., Kolios, G., & Bouros, D. (2011). Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis. Pulmonary Medicine, 2011(), 292-298. https://doi.org/10.1155/2011/849035